Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1987 Nov;41(5):839–866.

A controlled study of Tourette syndrome. VII. Summary: a common genetic disorder causing disinhibition of the limbic system.

D E Comings 1
PMCID: PMC1684345  PMID: 3314491

Abstract

Tourette syndrome (TS) is one of the most common genetic disorders affecting man. Approximately one in 100 individuals manifests one or more of the aspects of the TS gene. This series of papers has emphasized that although motor and vocal tics are the hallmark of TS, the complete range of behavioral problems is much broader. This spectrum of behavior can be explained on the basis of the TS gene causing an imbalance of the mesencephalic-mesolimbic dopamine pathways, resulting in disinhibition of the limbic system.

Full text

PDF
839

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albright P. S., Burnham W. M. Development of a new pharmacological seizure model: effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat. Epilepsia. 1980 Dec;21(6):681–689. doi: 10.1111/j.1528-1157.1980.tb04321.x. [DOI] [PubMed] [Google Scholar]
  2. Angrist B. M., Gershon S. The phenomenology of experimentally induced amphetamine psychosis--preliminary observations. Biol Psychiatry. 1970 Apr;2(2):95–107. [PubMed] [Google Scholar]
  3. Antelman S. M., Eichler A. J., Black C. A., Kocan D. Interchangeability of stress and amphetamine in sensitization. Science. 1980 Jan 18;207(4428):329–331. doi: 10.1126/science.7188649. [DOI] [PubMed] [Google Scholar]
  4. Bannon M. J., Elliott P. J., Alpert J. E., Goedert M., Iversen S. D., Iversen L. L. Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones. Nature. 1983 Dec 22;306(5945):791–792. doi: 10.1038/306791a0. [DOI] [PubMed] [Google Scholar]
  5. Bannon M. J., Roth R. H. Pharmacology of mesocortical dopamine neurons. Pharmacol Rev. 1983 Mar;35(1):53–68. [PubMed] [Google Scholar]
  6. Beckstead R. M., Domesick V. B., Nauta W. J. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 1979 Oct 19;175(2):191–217. doi: 10.1016/0006-8993(79)91001-1. [DOI] [PubMed] [Google Scholar]
  7. Bernardi G., Cherubini E., Marciani M. G., Mercuri N., Stanzione P. Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine. Brain Res. 1982 Aug 12;245(2):267–274. doi: 10.1016/0006-8993(82)90809-5. [DOI] [PubMed] [Google Scholar]
  8. Blanc G., Hervé D., Simon H., Lisoprawski A., Glowinski J., Tassin J. P. Response to stress of mesocortico-frontal dopaminergic neurones in rats after long-term isolation. Nature. 1980 Mar 20;284(5753):265–267. doi: 10.1038/284265a0. [DOI] [PubMed] [Google Scholar]
  9. Bowery N. G., Hill D. R., Hudson A. L., Doble A., Middlemiss D. N., Shaw J., Turnbull M. (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature. 1980 Jan 3;283(5742):92–94. doi: 10.1038/283092a0. [DOI] [PubMed] [Google Scholar]
  10. Brozoski T. J., Brown R. M., Rosvold H. E., Goldman P. S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 1979 Aug 31;205(4409):929–932. doi: 10.1126/science.112679. [DOI] [PubMed] [Google Scholar]
  11. Bunney B. S., Aghajanian G. K. Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques. Life Sci. 1976 Dec 1;19(11):1783–1789. doi: 10.1016/0024-3205(76)90087-4. [DOI] [PubMed] [Google Scholar]
  12. Butler I. J., Koslow S. H., Seifert W. E., Jr, Caprioli R. M., Singer H. S. Biogenic amine metabolism in Tourette syndrome. Ann Neurol. 1979 Jul;6(1):37–39. doi: 10.1002/ana.410060109. [DOI] [PubMed] [Google Scholar]
  13. Carli G., Zanchetti A. A study of pontine lesions suppressing deep sleep in the cat. Arch Ital Biol. 1965 Dec 10;103(4):751–788. [PubMed] [Google Scholar]
  14. Castall B., Marsden C. D., Naylor R. J., Pycock C. J. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei. Brain Res. 1977 Mar 4;123(1):89–111. doi: 10.1016/0006-8993(77)90645-x. [DOI] [PubMed] [Google Scholar]
  15. Chouinard G., Jones B. D. Schizophrenia as dopamine-deficiency disease. Lancet. 1978 Jul 8;2(8080):99–100. doi: 10.1016/s0140-6736(78)91409-5. [DOI] [PubMed] [Google Scholar]
  16. Cohen D. J., Shaywitz B. A., Caparulo B., Young J. G., Bowers M. B., Jr Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry. 1978 Feb;35(2):245–250. doi: 10.1001/archpsyc.1978.01770260123015. [DOI] [PubMed] [Google Scholar]
  17. Cohen D. J., Shaywitz B. A., Young J. G., Carbonari C. M., Nathanson J. A., Lieberman D., Bowers M. B., Jr, Maas J. W. Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry. 1979 Spring;18(2):320–341. doi: 10.1016/s0002-7138(09)61046-3. [DOI] [PubMed] [Google Scholar]
  18. Comings D. E., Comings B. G., Devor E. J., Cloninger C. R. Detection of major gene for Gilles de la Tourette syndrome. Am J Hum Genet. 1984 May;36(3):586–600. [PMC free article] [PubMed] [Google Scholar]
  19. Comings D. E., Comings B. G. Tourette's syndrome and attention deficit disorder with hyperactivity: are they genetically related? J Am Acad Child Psychiatry. 1984 Mar;23(2):138–146. doi: 10.1097/00004583-198403000-00004. [DOI] [PubMed] [Google Scholar]
  20. Costa E. Nonstriatal dopaminergic neurons: Section X. Morphine, amphetamine, and noncataleptogenic neuroleptics: Introduction: morphine, amphetamine, and noncataleptogenic neuroleptics. Adv Biochem Psychopharmacol. 1977;16:557–563. [PubMed] [Google Scholar]
  21. Costall B., Naylor R. J. The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system. Eur J Pharmacol. 1975 May;32(1):87–92. doi: 10.1016/0014-2999(75)90326-x. [DOI] [PubMed] [Google Scholar]
  22. Creese I., Burt D. R., Snyder S. H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 1976 Apr 30;192(4238):481–483. doi: 10.1126/science.3854. [DOI] [PubMed] [Google Scholar]
  23. Crowe R. R., Noyes R., Pauls D. L., Slymen D. A family study of panic disorder. Arch Gen Psychiatry. 1983 Oct;40(10):1065–1069. doi: 10.1001/archpsyc.1983.01790090027004. [DOI] [PubMed] [Google Scholar]
  24. Dabrowska J. On the mechanism of go-no go symmetrically reinforced task in dogs. Acta Neurobiol Exp (Wars) 1972;32(2):345–359. [PubMed] [Google Scholar]
  25. Devinsky O. Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement. Arch Neurol. 1983 Aug;40(8):508–514. doi: 10.1001/archneur.1983.04210070048013. [DOI] [PubMed] [Google Scholar]
  26. Drewe E. A. Go - no go learning after frontal lobe lesions in humans. Cortex. 1975 Mar;11(1):8–16. doi: 10.1016/s0010-9452(75)80015-3. [DOI] [PubMed] [Google Scholar]
  27. Eastgate S. M., Wright J. J., Werry J. S. Behavioural effects of methylphenidate in 6-hydroxydopamine-treated neonatal rats. Psychopharmacology (Berl) 1978 Jul 6;58(2):157–159. doi: 10.1007/BF00426899. [DOI] [PubMed] [Google Scholar]
  28. Erinoff L., MacPhail R. C., Heller A., Seiden L. S. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat. Brain Res. 1979 Mar 23;164:195–205. doi: 10.1016/0006-8993(79)90015-5. [DOI] [PubMed] [Google Scholar]
  29. Fadda F., Argiolas A., Melis M. R., Tissari A. H., Onali P. L., Gessa G. L. Stress-induced increase in 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in n. accumbens: reversal by diazepam. Life Sci. 1978 Nov 27;23(22):2219–2224. doi: 10.1016/0024-3205(78)90207-2. [DOI] [PubMed] [Google Scholar]
  30. Feinberg M., Carroll B. J. Effects of dopamine agonists and antagonists in Tourette's disease. Arch Gen Psychiatry. 1979 Aug;36(9):979–985. doi: 10.1001/archpsyc.1979.01780090065007. [DOI] [PubMed] [Google Scholar]
  31. Friedhoff A. J. Receptor maturation in pathogenesis and treatment of Tourette syndrome. Adv Neurol. 1982;35:133–140. [PubMed] [Google Scholar]
  32. Fuxe K., Andersson K., Locatelli V., Agnati L. F., Hökfelt T., Skirboll L., Mutt V. Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection. Eur J Pharmacol. 1980 Oct 17;67(2-3):329–331. doi: 10.1016/0014-2999(80)90521-x. [DOI] [PubMed] [Google Scholar]
  33. Galey D., Simon H., Le Moal M. Behavioral effects of lesions in the A10 dopaminergic area of the rat. Brain Res. 1977 Mar 18;124(1):83–97. doi: 10.1016/0006-8993(77)90865-4. [DOI] [PubMed] [Google Scholar]
  34. Gershon E. S., Hamovit J., Guroff J. J., Dibble E., Leckman J. F., Sceery W., Targum S. D., Nurnberger J. I., Jr, Goldin L. R., Bunney W. E., Jr A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry. 1982 Oct;39(10):1157–1167. doi: 10.1001/archpsyc.1982.04290100031006. [DOI] [PubMed] [Google Scholar]
  35. Goodwin D. W. Alcoholism and heredity. A review and hypothesis. Arch Gen Psychiatry. 1979 Jan;36(1):57–61. doi: 10.1001/archpsyc.1979.01780010063006. [DOI] [PubMed] [Google Scholar]
  36. Griffith J. D., Cavanaugh J., Held J., Oates J. A. Dextroamphetamine. Evaluation of psychomimetic properties in man. Arch Gen Psychiatry. 1972 Feb;26(2):97–100. doi: 10.1001/archpsyc.1972.01750200001001. [DOI] [PubMed] [Google Scholar]
  37. HARVEY J. A., HUNT H. F. EFFECT OF SEPTAL LESIONS ON THIRST IN THE RAT AS INDICATED BY WATER CONSUMPTION AND OPERANT RESPONDING FOR WATER REWARD. J Comp Physiol Psychol. 1965 Feb;59:49–56. doi: 10.1037/h0021600. [DOI] [PubMed] [Google Scholar]
  38. Haber S. N., Kowall N. W., Vonsattel J. P., Bird E. D., Richardson E. P., Jr Gilles de la Tourette's syndrome. A postmortem neuropathological and immunohistochemical study. J Neurol Sci. 1986 Sep;75(2):225–241. doi: 10.1016/0022-510x(86)90097-3. [DOI] [PubMed] [Google Scholar]
  39. Hanly P. J., Roberts D., Dobson K., Light R. B. Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia. Lancet. 1987 Feb 14;1(8529):351–354. doi: 10.1016/s0140-6736(87)91727-2. [DOI] [PubMed] [Google Scholar]
  40. Haracz J. L. The dopamine hypothesis: an overview of studies with schizophrenic patients. Schizophr Bull. 1982;8(3):438–469. doi: 10.1093/schbul/8.3.438. [DOI] [PubMed] [Google Scholar]
  41. Hervé D., Simon H., Blanc G., Lisoprawski A., Le Moal M., Glowinski J., Tassin J. P. Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat. Neurosci Lett. 1979 Dec;15(2-3):127–133. doi: 10.1016/0304-3940(79)96101-9. [DOI] [PubMed] [Google Scholar]
  42. Hill D. R., Bowery N. G. 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain. Nature. 1981 Mar 12;290(5802):149–152. doi: 10.1038/290149a0. [DOI] [PubMed] [Google Scholar]
  43. Hökfelt T., Ljungdahl A., Fuxe K., Johansson O. Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia. Science. 1974 Apr 12;184(4133):177–179. doi: 10.1126/science.184.4133.177. [DOI] [PubMed] [Google Scholar]
  44. Hökfelt T., Skirboll L., Rehfeld J. F., Goldstein M., Markey K., Dann O. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing. Neuroscience. 1980;5(12):2093–2124. doi: 10.1016/0306-4522(80)90127-x. [DOI] [PubMed] [Google Scholar]
  45. Iversen S. D., Koob G. F. Behavioral implications of dopaminergic neurons in the mesolimbic system. Adv Biochem Psychopharmacol. 1977;16:209–214. [PubMed] [Google Scholar]
  46. Iversen S. D., Mishkin M. Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Exp Brain Res. 1970 Nov 26;11(4):376–386. doi: 10.1007/BF00237911. [DOI] [PubMed] [Google Scholar]
  47. Jouvet M. Biogenic amines and the states of sleep. Science. 1969 Jan 3;163(3862):32–41. doi: 10.1126/science.163.3862.32. [DOI] [PubMed] [Google Scholar]
  48. Kalivas P. W., Burgess S. K., Nemeroff C. B., Prange A. J., Jr Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience. 1983 Mar;8(3):495–505. doi: 10.1016/0306-4522(83)90195-1. [DOI] [PubMed] [Google Scholar]
  49. Kelley A. E., Cador M., Stinus L. Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. Psychopharmacology (Berl) 1985;85(1):37–46. doi: 10.1007/BF00427319. [DOI] [PubMed] [Google Scholar]
  50. Kelly P. H., Iversen S. D. Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol. 1976 Nov;40(1):45–56. doi: 10.1016/0014-2999(76)90352-6. [DOI] [PubMed] [Google Scholar]
  51. Kelly P. H., Seviour P. W., Iversen S. D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 1975 Sep 5;94(3):507–522. doi: 10.1016/0006-8993(75)90233-4. [DOI] [PubMed] [Google Scholar]
  52. Kendler K. S., Gruenberg A. M., Strauss J. S. An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. IV. The relationship between major depressive disorder and schizophrenia. Arch Gen Psychiatry. 1982 Jun;39(6):639–642. doi: 10.1001/archpsyc.1982.04290060001001. [DOI] [PubMed] [Google Scholar]
  53. Kety S. S. Mental illness in the biological and adoptive relatives of schizophrenic adoptees: findings relevant to genetic and environmental factors in etiology. Am J Psychiatry. 1983 Jun;140(6):720–727. doi: 10.1176/ajp.140.6.720. [DOI] [PubMed] [Google Scholar]
  54. Klawans H. L., Margolin D. I. Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders. Arch Gen Psychiatry. 1975 Jun;32(6):725–732. doi: 10.1001/archpsyc.1975.01760240053004. [DOI] [PubMed] [Google Scholar]
  55. Kondo K., Nomura Y. Tourette syndrome in Japan: etiologic considerations based on associated factors and familial clustering. Adv Neurol. 1982;35:271–276. [PubMed] [Google Scholar]
  56. Laduron P., de Bie K., Leysen J. Specific effect of haloperidol on dopamine turnover in the frontal cortex. Naunyn Schmiedebergs Arch Pharmacol. 1977 Jan;296(2):183–185. doi: 10.1007/BF00508472. [DOI] [PubMed] [Google Scholar]
  57. Lavielle S., Tassin J. P., Thierry A. M., Blanc G., Herve D., Barthelemy C., Glowinski J. Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopaminergic neurons of the rat. Brain Res. 1979 Jun 8;168(3):585–594. doi: 10.1016/0006-8993(79)90311-1. [DOI] [PubMed] [Google Scholar]
  58. Le Moal M., Galey D., Cardo B. Behavioral effects of local injection of 6-hydroxydopamine in the medial ventral tegmentum in the rat. Possible role of the mesolimbic dopamingergic system. Brain Res. 1975 Apr 25;88(1):190–194. doi: 10.1016/0006-8993(75)90972-5. [DOI] [PubMed] [Google Scholar]
  59. LeMoal M., Stinus L., Galey D. Radiofrequency lesion of the ventral mesencephalic tegmentum: neurological and behavioral considerations. Exp Neurol. 1976 Mar;50(3):521–535. doi: 10.1016/0014-4886(76)90024-8. [DOI] [PubMed] [Google Scholar]
  60. Lebacq-Verheyden A. M., Bertness V., Kirsch I., Hollis G. F., McBride O. W., Battey J. Human gastrin-releasing peptide gene maps to chromosome band 18q21. Somat Cell Mol Genet. 1987 Jan;13(1):81–86. doi: 10.1007/BF02422302. [DOI] [PubMed] [Google Scholar]
  61. Lhermitte F. Human autonomy and the frontal lobes. Part II: Patient behavior in complex and social situations: the "environmental dependency syndrome". Ann Neurol. 1986 Apr;19(4):335–343. doi: 10.1002/ana.410190405. [DOI] [PubMed] [Google Scholar]
  62. Lhermitte F., Pillon B., Serdaru M. Human autonomy and the frontal lobes. Part I: Imitation and utilization behavior: a neuropsychological study of 75 patients. Ann Neurol. 1986 Apr;19(4):326–334. doi: 10.1002/ana.410190404. [DOI] [PubMed] [Google Scholar]
  63. Lindvall O., Björklund A., Divac I. Organization of catecholamine neurons projecting to the frontal cortex in the rat. Brain Res. 1978 Feb 17;142(1):1–24. doi: 10.1016/0006-8993(78)90173-7. [DOI] [PubMed] [Google Scholar]
  64. Lowe T. L., Cohen D. J., Detlor J., Kremenitzer M. W., Shaywitz B. A. Stimulant medications precipitate Tourette's syndrome. JAMA. 1982 Mar 26;247(12):1729–1731. [PubMed] [Google Scholar]
  65. MacLEAN P. D. Psychosomatic disease and the visceral brain; recent developments bearing on the Papez theory of emotion. Psychosom Med. 1949 Nov-Dec;11(6):338–353. doi: 10.1097/00006842-194911000-00003. [DOI] [PubMed] [Google Scholar]
  66. Markowitsch H. J., Pritzel M. Comparative analysis of prefrontal learning functions in rats, cats, and monkeys. Psychol Bull. 1977 Sep;84(5):817–837. [PubMed] [Google Scholar]
  67. Matthysse S. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed Proc. 1973 Feb;32(2):200–205. [PubMed] [Google Scholar]
  68. McClure F. D., Gordon M. Performance of disturbed hyperactive and nonhyperactive children on an objective measure of hyperactivity. J Abnorm Child Psychol. 1984 Dec;12(4):561–571. doi: 10.1007/BF00916850. [DOI] [PubMed] [Google Scholar]
  69. McGue M., Gottesman I. I., Rao D. C. The analysis of schizophrenia family data. Behav Genet. 1986 Jan;16(1):75–87. doi: 10.1007/BF01065480. [DOI] [PubMed] [Google Scholar]
  70. Merali Z., Johnston S., Zalcman S. Bombesin-induced behavioural changes: antagonism by neuroleptics. Peptides. 1983 Sep-Oct;4(5):693–697. doi: 10.1016/0196-9781(83)90020-7. [DOI] [PubMed] [Google Scholar]
  71. Mesulam M. M. Cocaine and Tourette's syndrome. N Engl J Med. 1986 Aug 7;315(6):398–398. doi: 10.1056/NEJM198608073150617. [DOI] [PubMed] [Google Scholar]
  72. Mesulam M. M. Frontal cortex and behavior. Ann Neurol. 1986 Apr;19(4):320–325. doi: 10.1002/ana.410190403. [DOI] [PubMed] [Google Scholar]
  73. Miller F. E., Heffner T. G., Kotake C., Seiden L. S. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion. Brain Res. 1981 Dec 14;229(1):123–132. doi: 10.1016/0006-8993(81)90750-2. [DOI] [PubMed] [Google Scholar]
  74. Mogenson G. J., Jones D. L., Yim C. Y. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol. 1980;14(2-3):69–97. doi: 10.1016/0301-0082(80)90018-0. [DOI] [PubMed] [Google Scholar]
  75. Moldofsky H., Tullis C., Lamon R. Multiple tic syndrome (Giles de la Tourette's syndrome). J Nerv Ment Dis. 1974 Oct;159(4):282–292. doi: 10.1097/00005053-197410000-00007. [DOI] [PubMed] [Google Scholar]
  76. Nauta W. J. The problem of the frontal lobe: a reinterpretation. J Psychiatr Res. 1971 Aug;8(3):167–187. doi: 10.1016/0022-3956(71)90017-3. [DOI] [PubMed] [Google Scholar]
  77. Naylor S. L., Sakaguchi A. Y., Spindel E., Chin W. W. Human gastrin-releasing peptide gene is located on chromosome 18. Somat Cell Mol Genet. 1987 Jan;13(1):87–91. doi: 10.1007/BF02422303. [DOI] [PubMed] [Google Scholar]
  78. Owen F., Cross A. J., Crow T. J., Longden A., Poulter M., Riley G. J. Increased dopamine-receptor sensitivity in schizophrenia. Lancet. 1978 Jul 29;2(8083):223–226. doi: 10.1016/s0140-6736(78)91740-3. [DOI] [PubMed] [Google Scholar]
  79. Pauls D. L., Leckman J. F. The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. N Engl J Med. 1986 Oct 16;315(16):993–997. doi: 10.1056/NEJM198610163151604. [DOI] [PubMed] [Google Scholar]
  80. Pert A., Moody T. W., Pert C. B., Dewald L. A., Rivier J. Bombesin: receptor distribution in brain and effects on nociception and locomotor activity. Brain Res. 1980 Jul 7;193(1):209–220. doi: 10.1016/0006-8993(80)90958-0. [DOI] [PubMed] [Google Scholar]
  81. Pijnenburg A. J., Honig W. M., Van Rossum J. M. Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacologia. 1975;41(2):87–95. doi: 10.1007/BF00421062. [DOI] [PubMed] [Google Scholar]
  82. Post R. M. Cocaine psychoses: a continuum model. Am J Psychiatry. 1975 Mar;132(3):225–231. doi: 10.1176/ajp.132.3.225. [DOI] [PubMed] [Google Scholar]
  83. Price R. A., Leckman J. F., Pauls D. L., Cohen D. J., Kidd K. K. Gilles de la Tourette's syndrome: tics and central nervous system stimulants in twins and nontwins. Neurology. 1986 Feb;36(2):232–237. doi: 10.1212/wnl.36.2.232. [DOI] [PubMed] [Google Scholar]
  84. Pycock C. J., Carter C. J., Kerwin R. W. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J Neurochem. 1980 Jan;34(1):91–99. doi: 10.1111/j.1471-4159.1980.tb04625.x. [DOI] [PubMed] [Google Scholar]
  85. Pycock C. J., Kerwin R. W., Carter C. J. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature. 1980 Jul 3;286(5768):74–76. doi: 10.1038/286074a0. [DOI] [PubMed] [Google Scholar]
  86. SCHWAB R. S., FABING H. D., PRICHARD J. S. Psychiatric symptoms and syndromes in Parkinson's disease. Am J Psychiatry. 1951 Jun;107(12):901–907. doi: 10.1176/ajp.107.12.901. [DOI] [PubMed] [Google Scholar]
  87. Sandyk R. The opioid system in Gilles de la Tourette's syndrome. Neurology. 1985 Mar;35(3):449–450. doi: 10.1212/wnl.35.3.449-b. [DOI] [PubMed] [Google Scholar]
  88. Schuckit M. A. Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry. 1986 Feb;143(2):140–147. doi: 10.1176/ajp.143.2.140. [DOI] [PubMed] [Google Scholar]
  89. Schulz D. W., Kalivas P. W., Nemeroff C. B., Prange A. J., Jr Bombesin-induced locomotor hyperactivity: evaluation of the involvement of the mesolimbic dopamine system. Brain Res. 1984 Jun 25;304(2):377–382. doi: 10.1016/0006-8993(84)90343-3. [DOI] [PubMed] [Google Scholar]
  90. Sessions G. R., Meyerhoff J. L., Kant G. J., Koob G. F. Effects of lesions of the ventral medial tegmentum on locomotor activity, biogenic amines and responses to amphetamine in rats. Pharmacol Biochem Behav. 1980 Apr;12(4):603–608. doi: 10.1016/0091-3057(80)90195-1. [DOI] [PubMed] [Google Scholar]
  91. Shaywitz B. A., Klopper J. H., Gordon J. W. Methylphenidate in 6-hydroxydopamine-treated developing rat pups. Effects on activity and maze performance. Arch Neurol. 1978 Jul;35(7):463–469. doi: 10.1001/archneur.1978.00500310065014. [DOI] [PubMed] [Google Scholar]
  92. Shaywitz B. A., Klopper J. H., Yager R. D., Gordon J. W. Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine. Nature. 1976 May 13;261(5556):153–155. doi: 10.1038/261153a0. [DOI] [PubMed] [Google Scholar]
  93. Shaywitz B. A., Yager R. D., Klopper J. H. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science. 1976 Jan 23;191(4224):305–308. doi: 10.1126/science.942800. [DOI] [PubMed] [Google Scholar]
  94. Simon H., Scatton B., Moal M. L. Dopaminergic A10 neurones are involved in cognitive functions. Nature. 1980 Jul 10;286(5769):150–151. doi: 10.1038/286150a0. [DOI] [PubMed] [Google Scholar]
  95. Skirboll L. R., Grace A. A., Hommer D. W., Rehfeld J., Goldstein M., Hökfelt T., Bunney B. S. Peptide-monoamine coexistence: studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons. Neuroscience. 1981;6(11):2111–2124. doi: 10.1016/0306-4522(81)90002-6. [DOI] [PubMed] [Google Scholar]
  96. Stevens J. R. An anatomy of schizophrenia? Arch Gen Psychiatry. 1973 Aug;29(2):177–189. doi: 10.1001/archpsyc.1973.04200020023003. [DOI] [PubMed] [Google Scholar]
  97. Stinus L., Gaffori O., Simon H., Le Moal M. Disappearance of hoarding and disorganization of eating behavior after ventral mesencephalic tegmentum lesions in rats. J Comp Physiol Psychol. 1978 Apr;92(2):289–296. doi: 10.1037/h0077467. [DOI] [PubMed] [Google Scholar]
  98. Stinus L., Gaffori O., Simon H., Le Moal M. Small doses of apomorphine and chronic administration of d-amphetamine reduce locomotor hyperactivity produced by radiofrequency lesions of dopaminergic A10 neurons area. Biol Psychiatry. 1977 Dec;12(6):719–732. [PubMed] [Google Scholar]
  99. Stinus L., Kelley A. E., Iversen S. D. Increased spontaneous activity following substance P infusion into A10 dopaminergic area. Nature. 1978 Dec 7;276(5688):616–618. doi: 10.1038/276616a0. [DOI] [PubMed] [Google Scholar]
  100. Stinus L., Koob G. F., Ling N., Bloom F. E., Le Moal M. Locomotor activation induced by infusion of endorphins into the ventral tegmental area: evidence for opiate-dopamine interactions. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2323–2327. doi: 10.1073/pnas.77.4.2323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. TERZIAN H., ORE G. D. Syndrome of Klüver and Bucy; reproduced in man by bilateral removal of the temporal lobes. Neurology. 1955 Jun;5(6):373–380. doi: 10.1212/wnl.5.6.373. [DOI] [PubMed] [Google Scholar]
  102. Taghzouti K., Louilot A., Herman J. P., Le Moal M., Simon H. Alternation behavior, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the rat. Behav Neural Biol. 1985 Nov;44(3):354–363. doi: 10.1016/s0163-1047(85)90640-5. [DOI] [PubMed] [Google Scholar]
  103. Taghzouti K., Simon H., Louilot A., Herman J. P., Le Moal M. Behavioral study after local injection of 6-hydroxydopamine into the nucleus accumbens in the rat. Brain Res. 1985 Sep 30;344(1):9–20. doi: 10.1016/0006-8993(85)91184-9. [DOI] [PubMed] [Google Scholar]
  104. Taghzouti K., Simon H., Tazi A., Dantzer R., Le Moal M. The effect of 6-OHDA lesions of the lateral septum on schedule-induced polydipsia. Behav Brain Res. 1985 Jan;15(1):1–8. doi: 10.1016/0166-4328(85)90012-9. [DOI] [PubMed] [Google Scholar]
  105. Tassin J. P., Stinus L., Simon H., Blanc G., Thierry A. M., Le Moal M., Cardo B., Glowinski J. Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res. 1978 Feb 10;141(2):267–281. doi: 10.1016/0006-8993(78)90197-x. [DOI] [PubMed] [Google Scholar]
  106. Thieme R. E., Dijkstra H., Stoof J. C. An evaluation of the young dopamine-lesioned rat as an animal model for minimal brain dysfunction (MBD). Psychopharmacology (Berl) 1980 Feb;67(2):165–169. doi: 10.1007/BF00431972. [DOI] [PubMed] [Google Scholar]
  107. Thierry A. M., Tassin J. P., Blanc G., Glowinski J. Selective activation of mesocortical DA system by stress. Nature. 1976 Sep 16;263(5574):242–244. doi: 10.1038/263242a0. [DOI] [PubMed] [Google Scholar]
  108. Torrey E. F., Peterson M. R. Schizophrenia and the limbic system. Lancet. 1974 Oct 19;2(7886):942–946. doi: 10.1016/s0140-6736(74)91143-x. [DOI] [PubMed] [Google Scholar]
  109. Trimble M. R., Cummings J. L. Neuropsychiatric disturbances following brainstem lesions. Br J Psychiatry. 1981 Jan;138:56–59. doi: 10.1192/bjp.138.1.56. [DOI] [PubMed] [Google Scholar]
  110. Valzelli L. The "isolation syndrome" in mice. Psychopharmacologia. 1973 Aug 3;31(4):305–320. doi: 10.1007/BF00421275. [DOI] [PubMed] [Google Scholar]
  111. WOOD C. D. Behavioral changes following discrete lesions of temporal lobe structures. Neurology. 1958 Mar;8(3):215–220. doi: 10.1212/wnl.8.3.215. [DOI] [PubMed] [Google Scholar]
  112. Weiss G., Minde K., Werry J. S., Douglas V., Nemeth E. Studies on the hyperactive child. 8. Five-year follow-up. Arch Gen Psychiatry. 1971 May;24(5):409–414. doi: 10.1001/archpsyc.1971.01750110021004. [DOI] [PubMed] [Google Scholar]
  113. Weissman M. M., Gershon E. S., Kidd K. K., Prusoff B. A., Leckman J. F., Dibble E., Hamovit J., Thompson W. D., Pauls D. L., Guroff J. J. Psychiatric disorders in the relatives of probands with affective disorders. The Yale University--National Institute of Mental Health Collaborative Study. Arch Gen Psychiatry. 1984 Jan;41(1):13–21. doi: 10.1001/archpsyc.1984.01790120015003. [DOI] [PubMed] [Google Scholar]
  114. Wolf P., Olpe H. R., Avrith D., Haas H. L. GABAergic inhibition of neurons in the ventral tegmental area. Experientia. 1978 Jan 15;34(1):73–74. doi: 10.1007/BF01921910. [DOI] [PubMed] [Google Scholar]
  115. Yim C. Y., Mogenson G. J. Electrophysiological studies of neurons in the ventral tegmental area of Tsai. Brain Res. 1980 Jan 13;181(2):301–313. doi: 10.1016/0006-8993(80)90614-9. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES